Research Report on China Condom Industry, 2017-2021

According to CRI, residents’ demand for living qualities keeps rising with the development of China’s economy. Functions of condoms expand from mere contraception to prevention of STDs and improving the quality of sex life.

The Chinese government loosened control over condom industry in2002, which gained rapid development afterwards. Annual production volume of condoms was merely about 1 billion in 1995 while the number exceeded 10 billion in China in 2016. By the end of 2016, annual production capacity of condoms exceeded 18 billion in China. Apart from satisfying the domestic demand, condoms produced in China are largely exported to Hong Kong, South Africa, Russia, Britain, etc. The export value of condoms exceeded USD 72 million in China in 2016.


According to CRI, due to the family planning policies in China, the Chinese government annually purchases over 1 billion condoms for free distribution in order to encourage population control. Governments on all levels purchase condoms from 20 designated enterprises every year. Although the amount purchased by the Chinese government is huge, average unit price is merely CNY 0.2-0.5. However, due to the low quality and the lack of distributing channels, the Chinese government has not achieved the expected effects. Therefore, governments on all levels now have gradually reduced the purchasing amount.

According to CRI, the condom market excluding the purchasing of the Chinese government is the commercial market where the competition is fairly fierce. There are hundreds of condom brand enterprises in China, most of which do not produce condoms themselves but rely on ODM/OEM enterprises. In 2016, the retail price of per condom in commercial condom market of China was CNY 0.5-20, and the market size exceeded CNY 8 billion with high profit margin, making it the focus of competition. Condom brands can be classified into 3 categories in China market: Brands of the first category have production bases in China and manufacture their own products in China market, such as Durex, JISSBON, etc. Brands of the second category sell products in China while setting production bases overseas, such as Okamoto. Brands of the third category have no production base themselves and completely depend on OEM, such as Daxiang and several other new brands. In China, some condom producers completely survive on government procurement and OEM with low sales volume of their own brands.

China imports a large amount of condoms annually because partial consumers believe that imported condoms are of better quality than those made in China, and the major sources include Thailand, Japan, Malaysia, etc. In 2016, import value of condoms reached USD 156 million in China with a trade deficit of USD 84 million.

According to CRI, the potential condom market is huge in China, because the total population approached 1.4 billion by the end of 2016, of which there are over 600 million sexually active people. Premarital and commercial sex behaviors have been in a growing trend in the last 30 years, which promotes the demand for condoms. Although commercial sex behaviors are prohibited by the Chinese law, they cannot be eliminated. Therefore, the Chinese government has required night clubs, hotels and other public places to provide condoms so as to control the spread of AIDS and other STDs.

On May 26, 2017, Chinese public enterprise, Renfu Medicine, together with Citic Capital, claimed to purchase Ansell Ltd. including its global sexual health business as the subsidiary JISSBON Company for USD 600 million. After this deal, Renfu Medicine and Citic Capital will own Ansell’s all sexual health business, including the business of condoms, lubricant and sex toys. After the acquisition, Renfu Medicine will replace Ansell to become the leader in sexual health field and the second largest enterprise in global condom market. It is estimated that this acquisition will change the competition pattern in China condom market in the next few years.